Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Microbiotix Inc.

Latest From Microbiotix Inc.

O'Neill: UK 'Lost Focus' On Antibiotic Crisis And Pharma Must Do More

The time for talking is over when it comes to antimicrobial resistance, says Jim O'Neill, urging the government to 'rediscover the passion for championing' initiatives in the UK, notably the new AMR Centre in Alderley Park near Manchester.

Infectious Diseases Research & Development

UK R&D Centre for Antimicrobial Resistance Goes Into Battle

The UK's recently launched AMR Centre has launched two R&D collaborations and plans two more this year.

Business Strategies Commercial

Finance Watch: Canaan Closes New VC Fund; CARB-X Backs More Antibiotics

Canaan raised $800m for tech and health care investments. Also, six companies closed VC rounds, CARB-X backed more antibiotics, CIRM funded BrainStorm and Sarepta led recent offerings.

Financing Business Strategies

New Anti-CMV Therapies Post-Transplant: Merck & Co Leads The Pack

Merck & Co’s investigational anti-CMV therapy letermovir is expected to be filed for approval later this year and could be the first of a new generation of anti-CMV therapies, following top-line Phase III data showing it reduced all-cause mortality in bone marrow transplant patients.

Clinical Trials Market Intelligence
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Microbiotix Inc.
  • Senior Management
  • Terry L Bowlin, PhD, Pres. & CEO
    Donald T Moir, PhD, CSO
    Richard Gauthier, Head, Bus. Dev.
  • Contact Info
  • Microbiotix Inc.
    Phone: (508) 757-2800
    One Innovation Dr.
    #3 Biotech Bldg
    Worcester, MA 01605